Please enable JavaScript to continue using this application.

Compare tickers

Valuation, margins, and growth side by side.

Compare $CURA.TO vs $ELVN | Chartloom

Compare

$CURA.TO vs $ELVN

CURA.TO

Error

ELVN

Enliven Therapeutics Inc

Compare $CURA.TO vs $ELVN

CURA.TO

Error

ELVNEnliven Therapeutics Inc

CURA.TO

Market cap

—

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

—

52W performance

—

FCF yield

—

ELVNEnliven Therapeutics Inc

Market cap

$2.76B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

154.1%

52W performance

89.7%

FCF yield

-2.4%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CURA.TO

ELVN

Not enough overlapping price history for this window.

Detailed metrics comparison

CURA.TO

ELVN

Enliven Therapeutics Inc

Market Cap

CURA.TO

ELVN$2.76B

Enterprise Value

CURA.TO

ELVN$2.62B

Price

CURA.TO

ELVN$39.49

P/E Ratio

CURA.TO

ELVNN/A

P/S Ratio

CURA.TO

ELVN0.00x

EV/Sales

CURA.TO

ELVN0.00x

EV/EBITDA

CURA.TO

ELVN770.73x

P/B Ratio

CURA.TO

ELVN3.35x

P/FCF Ratio

CURA.TO

ELVNN/A

EV/FCF

CURA.TO

ELVN-39.11x

PEG Ratio

CURA.TO

ELVNN/A

Forward P/E (NTM)

CURA.TO

ELVNN/A

Forward P/S (NTM)

CURA.TO

ELVNN/A

Revenue (TTM)

CURA.TO

ELVN$0

Revenue Growth (YoY)

CURA.TO

ELVNN/A

Forward Rev Growth

CURA.TO

ELVN28.4%

Gross Margin (TTM)

CURA.TO

ELVN0.0%

Operating Margin (TTM)

CURA.TO

ELVN0.0%

EBITDA Margin (TTM)

CURA.TO

ELVN0.0%

Net Margin (TTM)

CURA.TO

ELVN0.0%

FCF Margin (TTM)

CURA.TO

ELVNN/A

Net Income (TTM)

CURA.TO

ELVN$-106M

FCF (TTM)

CURA.TO

ELVN$-67M

EPS (TTM)

CURA.TO

ELVN-$1.60

ROE (TTM)

CURA.TO

ELVN-1855.0%

ROA (TTM)

CURA.TO

ELVN-1809.0%

ROIC (TTM)

CURA.TO

ELVN-1855.0%

Cash

CURA.TO

ELVN$136M

Debt

CURA.TO

ELVN$0

Net Cash/Debt

CURA.TO

ELVN$136M

Current Ratio (TTM)

CURA.TO

ELVN64.07x

Quick Ratio (TTM)

CURA.TO

ELVN63.21x

Debt/Equity (TTM)

CURA.TO

ELVN0.00x

Debt/Assets (TTM)

CURA.TO

ELVN0.0%

Interest Coverage (TTM)

CURA.TO

ELVNN/A

Net Debt/EBITDA (TTM)

CURA.TO

ELVN0.00x

Beta

CURA.TO

ELVN0.55

52W Performance

CURA.TO

ELVN89.7%

YTD Performance

CURA.TO

ELVN154.1%

% from 52W High

CURA.TO

ELVN-36.6%

% from 52W Low

CURA.TO

ELVN167.1%

Asset Turnover (TTM)

CURA.TO

ELVN0.00x

FCF Yield (TTM)

CURA.TO

ELVN-2.4%

Earnings Yield (TTM)

CURA.TO

ELVN-3.8%

Dividend Yield (TTM)

CURA.TO

ELVNN/A

Rule of 40

CURA.TO

ELVN0.0

EV/GP/RG

CURA.TO

ELVNN/A

Ticker research

View CURA.TO research View ELVN research

Metric	CURA.TO	ELVN Enliven Therapeutics Inc
Market & Valuation
Market Cap		$2.76B
Enterprise Value		$2.62B
Price		$39.49
P/E Ratio		N/A
P/S Ratio		0.00x
EV/Sales		0.00x
EV/EBITDA		770.73x
P/B Ratio		3.35x
P/FCF Ratio		N/A
EV/FCF		-39.11x
PEG Ratio		N/A
Forward P/E (NTM)		N/A
Forward P/S (NTM)		N/A
Revenue & Growth
Revenue (TTM)		$0
Revenue Growth (YoY)		N/A
Forward Rev Growth		28.4%
Profitability
Gross Margin (TTM)		0.0%
Operating Margin (TTM)		0.0%
EBITDA Margin (TTM)		0.0%
Net Margin (TTM)		0.0%
FCF Margin (TTM)		N/A
Net Income (TTM)		$-106M
FCF (TTM)		$-67M
EPS (TTM)		-$1.60
ROE (TTM)		-1855.0%
ROA (TTM)		-1809.0%
ROIC (TTM)		-1855.0%
Financial Health
Cash		$136M
Debt		$0
Net Cash/Debt		$136M
Current Ratio (TTM)		64.07x
Quick Ratio (TTM)		63.21x
Debt/Equity (TTM)		0.00x
Debt/Assets (TTM)		0.0%
Interest Coverage (TTM)		N/A
Net Debt/EBITDA (TTM)		0.00x
Performance
Beta		0.55
52W Performance		89.7%
YTD Performance		154.1%
% from 52W High		-36.6%
% from 52W Low		167.1%
Efficiency & Yields
Asset Turnover (TTM)		0.00x
FCF Yield (TTM)		-2.4%
Earnings Yield (TTM)		-3.8%
Dividend Yield (TTM)		N/A
Other
Rule of 40		0.0
EV/GP/RG		N/A
Ticker research	View CURA.TO research	View ELVN research

Valuation

Growth & revenue

Profitability & performance

Detailed metrics comparison

CURA.TO

ELVN

Enliven Therapeutics Inc

Market Cap

CURA.TO

ELVN$2.76B

Enterprise Value

CURA.TO

ELVN$2.62B

Price

CURA.TO

ELVN$39.49

P/E Ratio

CURA.TO

ELVNN/A

P/S Ratio

CURA.TO

ELVN0.00x

EV/Sales

CURA.TO

ELVN0.00x

EV/EBITDA

CURA.TO

ELVN770.73x

P/B Ratio

CURA.TO

ELVN3.35x

P/FCF Ratio

CURA.TO

ELVNN/A

EV/FCF

CURA.TO

ELVN-39.11x

PEG Ratio

CURA.TO

ELVNN/A

Forward P/E (NTM)

CURA.TO

ELVNN/A

Forward P/S (NTM)

CURA.TO

ELVNN/A

Revenue (TTM)

CURA.TO

ELVN$0

Revenue Growth (YoY)

CURA.TO

ELVNN/A

Forward Rev Growth

CURA.TO

ELVN28.4%

Gross Margin (TTM)

CURA.TO

ELVN0.0%

Operating Margin (TTM)

CURA.TO

ELVN0.0%

EBITDA Margin (TTM)

CURA.TO

ELVN0.0%

Net Margin (TTM)

CURA.TO

ELVN0.0%

FCF Margin (TTM)

CURA.TO

ELVNN/A

Net Income (TTM)

CURA.TO

ELVN$-106M

FCF (TTM)

CURA.TO

ELVN$-67M

EPS (TTM)

CURA.TO

ELVN-$1.60

ROE (TTM)

CURA.TO

ELVN-1855.0%

ROA (TTM)

CURA.TO

ELVN-1809.0%

ROIC (TTM)

CURA.TO

ELVN-1855.0%

Cash

CURA.TO

ELVN$136M

Debt

CURA.TO

ELVN$0

Net Cash/Debt

CURA.TO

ELVN$136M

Current Ratio (TTM)

CURA.TO

ELVN64.07x

Quick Ratio (TTM)

CURA.TO

ELVN63.21x

Debt/Equity (TTM)

CURA.TO

ELVN0.00x

Debt/Assets (TTM)

CURA.TO

ELVN0.0%

Interest Coverage (TTM)

CURA.TO

ELVNN/A

Net Debt/EBITDA (TTM)

CURA.TO

ELVN0.00x

Beta

CURA.TO

ELVN0.55

52W Performance

CURA.TO

ELVN89.7%

YTD Performance

CURA.TO

ELVN154.1%

% from 52W High

CURA.TO

ELVN-36.6%

% from 52W Low

CURA.TO

ELVN167.1%

Asset Turnover (TTM)

CURA.TO

ELVN0.00x

FCF Yield (TTM)

CURA.TO

ELVN-2.4%

Earnings Yield (TTM)

CURA.TO

ELVN-3.8%

Dividend Yield (TTM)

CURA.TO

ELVNN/A

Rule of 40

CURA.TO

ELVN0.0

EV/GP/RG

CURA.TO

ELVNN/A

Ticker research

View CURA.TO research View ELVN research

Metric	CURA.TO	ELVN Enliven Therapeutics Inc
Market & Valuation
Market Cap		$2.76B
Enterprise Value		$2.62B
Price		$39.49
P/E Ratio		N/A
P/S Ratio		0.00x
EV/Sales		0.00x
EV/EBITDA		770.73x
P/B Ratio		3.35x
P/FCF Ratio		N/A
EV/FCF		-39.11x
PEG Ratio		N/A
Forward P/E (NTM)		N/A
Forward P/S (NTM)		N/A
Revenue & Growth
Revenue (TTM)		$0
Revenue Growth (YoY)		N/A
Forward Rev Growth		28.4%
Profitability
Gross Margin (TTM)		0.0%
Operating Margin (TTM)		0.0%
EBITDA Margin (TTM)		0.0%
Net Margin (TTM)		0.0%
FCF Margin (TTM)		N/A
Net Income (TTM)		$-106M
FCF (TTM)		$-67M
EPS (TTM)		-$1.60
ROE (TTM)		-1855.0%
ROA (TTM)		-1809.0%
ROIC (TTM)		-1855.0%
Financial Health
Cash		$136M
Debt		$0
Net Cash/Debt		$136M
Current Ratio (TTM)		64.07x
Quick Ratio (TTM)		63.21x
Debt/Equity (TTM)		0.00x
Debt/Assets (TTM)		0.0%
Interest Coverage (TTM)		N/A
Net Debt/EBITDA (TTM)		0.00x
Performance
Beta		0.55
52W Performance		89.7%
YTD Performance		154.1%
% from 52W High		-36.6%
% from 52W Low		167.1%
Efficiency & Yields
Asset Turnover (TTM)		0.00x
FCF Yield (TTM)		-2.4%
Earnings Yield (TTM)		-3.8%
Dividend Yield (TTM)		N/A
Other
Rule of 40		0.0
EV/GP/RG		N/A
Ticker research	View CURA.TO research	View ELVN research